Roche launches GS FLX+ System software update

Monday, August 12, 2013 03:37 PM

Roche has launched a software update that extends the range of amplicon lengths available for targeted next-generation sequencing studies on the 454 GS FLX+ System. The latest software enables sequencing of amplicons up to 800bp while maintaining >99% accuracy over the length of the read.

High-quality sequencing of even longer amplicons up to 1,100bp has been successfully demonstrated in early access testing. The long read improvements allow researchers to obtain more complete coverage of target gene regions using fewer amplicons, both simplifying experimental design and improving the biological relevance of sequencing results.

“We are actively working to make these same long read developments available on our benchtop GS Junior System in 2014,” said Frank Pitzer, president, Roche Sequencing Solutions.

Long amplicon read lengths are critical for a variety of targeted sequencing applications including human gene sequencing and viral drug resistance studies as well as microbial community analysis. Early results of targeted sequencing of 16S and 18S ribosomal RNA genes to accurately profile mixed communities have shown the extended amplicon read lengths allow coverage of more variable regions in a single read. This results in more precise taxonomic assignment of organisms down to the genus and even species level, which is of particular importance for microbiome studies in clinical research.

Early access testing of the latest GS FLX+ software v2.9 was led by metagenomics researchers who also have optimized open source microbial community profiling tools QIIME and mothur for the latest long read data.  

“The new software for the GS FLX+ System will enable researchers to obtain longer sequence reads from 16S rRNA gene amplicons without sacrificing data quality,” said Patrick Schloss, Ph.D., assistant professor at the University of Michigan and author of mothur. “This is a great advance for microbial ecologists since it will enable them to get better taxonomic classification of their data.”

The GS FLX+ long amplicons will allow more comprehensive detection of genetic variations in human gene panels by spanning more introns and exons. The long reads also improve haplotype phasing of more distantly linked variants, which is critical for genotyping of highly polymorphic regions of the genome such as the Human Leukocyte Antigen (HLA) gene. Longer amplicon read lengths also significantly ease sequencing experimental design, workflow and analysis by allowing optimal primer placement, the use of fewer amplicons to cover target regions and direct transition of pre-existing Sanger amplicons to the GS FLX+ System.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs